> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# OGD Sets Up ANDA Dashboard to Track User Fee Program
- URL: https://www.fdaweb.com/ogd-sets-up-anda-dashboard-to-track-user-fee-program/
- Published: 2016-02-05T12:00:00.000Z
- Updated: 2026-09-15T02:33:45.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5134688

> CDER’s Office of Generics Drugs has released a “dashboard” [report](http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/UCM484740.pdf?ref=fdaweb.com) designed to improve transparency and communication as it implements the Generic Drug User Fee Amendments of 2012 (GDUFA). The report includes a current submission status on the last three years’ Application Cohorts and the “total original ANDA workload activity” for all unapproved applications. For example, it shows 3,470 ANDAs in backlog; of these, 1,928 have had one review communication issued and another 842 are awaiting an industry response after an “additional information” request was sent from OGD.